Business Context and Reporting Period
Littelfuse, Inc. filed this Form 8-K on September 17, 2026, reporting an event that occurred on September 15, 2026. The filing concerns an amendment to agreements related to the company's 200mm wafer fab facility in Dortmund, Germany, originally acquired from Elmos Semiconductor SE in 2023 and operationalized in 2024.
Key Financial Metrics
The filing discloses a specific one-time financial obligation resulting from the amendment:
- Amendment Fee: €24.6 million payable to Elmos Semiconductor SE.
- Recognition Period: The fee will be recorded in the third quarter financial results for 2026.
- Other Metrics: The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The primary material change is the execution of an Amended Share Purchase Agreement and Supply and Services Agreement involving Dortmund Semiconductor GmbH (DoSemi), Elmos, and Littelfuse Holding GmbH. Key modifications include:
- Release of cross-guarantees previously provided by Littelfuse entities.
- Modification of certain transfer restrictions.
- Updates to selected commercial terms regarding the existing supply relationship.
Outlook, Commentary, and Risks
Management commentary indicates the amendment is designed to enhance strategic flexibility, accelerate and simplify legacy contractual arrangements, and optimize the DoSemi asset over time. The changes aim to support the company's broader semiconductor portfolio strategy and focus on high-value growth opportunities. The filing does not explicitly list new risks or contingencies beyond the standard disclosure that the information is not deemed "filed" for Section 18 liability purposes.
Investor Verification Checklist
- Verify the impact of the €24.6 million one-time fee on the Q3 2026 earnings report.
- Review the specific details of the released cross-guarantees to assess changes in contingent liabilities.
- Confirm how the updated commercial terms affect future capacity sharing and supply chain stability with Elmos.
- Monitor subsequent filings for any further capital allocation decisions regarding the DoSemi asset.